Hongmin Li Selected Research

Therapeutics

10/2023	The extracellular matrix as modifier of neuroinflammation and recovery in ischemic stroke and intracerebral hemorrhage.
9/2023	Obesity in acute ischaemic stroke patients treated with intravenous thrombolysis therapy.
1/2023	Mitochondrial dysfunction in hearing loss: Oxidative stress, autophagy and NLRP3 inflammasome.
3/2022	Efficacy and safety of Chinese herbal medicine Jianpi formulas for atopic dermatitis: Evidence from 11 randomized controlled trials.
1/2021	Drug repurposing approach to combating coronavirus: Potential drugs and drug targets.
12/2020	Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo.
1/2020	Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential.
8/2019	NIS and epithelial-mesenchymal transition marker expression of circulating tumor cells for predicting and monitoring the radioactive iodine-131 therapy effect in differentiated thyroid cancers.
1/2018	Associations of Genetic Variations in MicroRNA Seed Regions With Acute Adverse Events and Survival in Patients With Rectal Cancer Receiving Postoperative Chemoradiation Therapy.
1/2018	Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongmin Li Research Topics

Disease

22	Neoplasms (Cancer) 10/2023 - 07/2008
10	Infections 12/2020 - 09/2003
6	Congenital Preauricular Fistulae 10/2018 - 10/2016
5	Dengue (Dengue Fever) 02/2022 - 09/2003
4	Stroke (Strokes) 05/2024 - 01/2018
4	Lung Neoplasms (Lung Cancer) 12/2021 - 05/2015
4	Neoplasm Metastasis (Metastasis) 12/2018 - 07/2008
3	Multiple Sclerosis 05/2024 - 11/2019
3	Hypoxia (Hypoxemia) 01/2024 - 07/2022
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 12/2017
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 03/2009
3	Inflammation (Inflammations) 01/2023 - 01/2014
3	COVID-19 01/2023 - 01/2020
3	Zika Virus Infection 04/2022 - 10/2020
3	Rectal Neoplasms (Rectal Cancer) 07/2019 - 01/2018
3	Carcinogenesis 01/2018 - 10/2015
3	Tuberculosis (Tuberculoses) 04/2013 - 04/2002
2	Demyelinating Diseases (Demyelinating Disease) 05/2024 - 01/2022
2	Muscular Diseases (Myopathy) 12/2023 - 01/2023
2	Ischemic Stroke 09/2023 - 01/2018
2	Virus Diseases (Viral Diseases) 01/2023 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2023
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 01/2021
2	Viremia 12/2020 - 08/2017
2	Flavivirus Infections 12/2020 - 01/2018
2	Thrombosis (Thrombus) 10/2019 - 11/2017
2	Atrial Fibrillation 01/2019 - 02/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2015 - 09/2011
2	Yellow Fever 08/2010 - 04/2007
1	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2024
1	Alzheimer Disease (Alzheimer's Disease) 05/2024
1	Eczema 02/2024
1	Polyploidy 01/2024
1	Ovarian Torsion 01/2024
1	Obesity 09/2023
1	Hypertrophy 01/2023
1	Hepatitis B 01/2023
1	Hepatitis C 01/2023
1	Human Influenza (Influenza) 01/2023
1	Diarrhea 01/2023
1	Deafness (Deaf Mutism) 01/2023
1	Hearing Loss (Hearing Impairment) 01/2023
1	Cerebral Hemorrhage 01/2023
1	Pathologic Complete Response 03/2022
1	Atopic Dermatitis (Atopic Eczema) 03/2022

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2003
7	MicroRNAs (MicroRNA)IBA 12/2018 - 02/2015
5	ferric chlorideIBA 10/2018 - 10/2016
4	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 01/2013
4	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2019
4	Peptide Hydrolases (Proteases)FDA Link 02/2022 - 12/2013
4	Biomarkers (Surrogate Marker)IBA 07/2019 - 06/2015
4	CoagulantsIBA 10/2018 - 10/2016
4	Aluminum ChlorideIBA 11/2017 - 10/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 05/2014
3	AntioxidantsIBA 01/2023 - 09/2021
3	EnzymesIBA 07/2022 - 11/2020
3	Therapeutic UsesIBA 01/2022 - 11/2002
3	Niclosamide FDA Link 10/2020 - 01/2019
3	AluminumIBA 11/2017 - 10/2016
2	Matrix Metalloproteinases (MMPs)IBA 10/2023 - 01/2022
2	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 12/2021
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 07/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 07/2022
2	Food Additives (Food Additive)IBA 04/2022 - 01/2018
2	Erythrosine (Erythrosin)IBA 04/2022 - 01/2018
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 01/2021
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2020 - 01/2019
2	Sirolimus (Rapamycin)FDA Link 01/2020 - 11/2018
2	Transforming Growth Factor-beta Type I ReceptorIBA 12/2018 - 12/2017
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017 - 12/2014
2	Peptides (Polypeptides)IBA 01/2017 - 12/2014
2	Complementary DNA (cDNA)IBA 10/2013 - 09/2008
2	m7GpppAIBA 08/2010 - 04/2007
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 05/2024
1	ProteomeIBA 05/2024
1	fibulin 2IBA 05/2024
1	dupilumabIBA 02/2024
1	PlatinumIBA 01/2024
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2024
1	Rad51 RecombinaseIBA 01/2024
1	Diosmin (Daflon)IBA 12/2023
1	MelatoninIBA 10/2023
1	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2023
1	neoruscogeninIBA 01/2023
1	nitazoxanide (NTZ)FDA Link 01/2023
1	IronIBA 01/2023
1	TEA Domain Transcription FactorsIBA 01/2023
1	InflammasomesIBA 01/2023
1	CannabidiolIBA 01/2023
1	salicylamideIBA 01/2023
1	NeurocanIBA 01/2023
1	sulforaphaneIBA 07/2022
1	TabletsIBA 01/2022

Therapy/Procedure

17	Therapeutics 10/2023 - 04/2002
4	Drug Therapy (Chemotherapy) 01/2024 - 12/2021
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2022 - 04/2020
2	Radiotherapy 01/2022 - 06/2015
2	Chemoradiotherapy 07/2019 - 01/2019
1	Precision Medicine 01/2022